PDZD11 and metastatic malignant neoplasm in the lymph nodes: As shown in Figures 2B–I, according to subgroup analysis based on race, gender, age, weight, and lymph node metastasis status, the mRNA expression of PDZD11 in LIHC patients was evidently higher than that in healthy individuals.